Wu et al. showed that catalpol may reduce blood glucose and serum inflammatory factor levels in diabetic mice by inhibiting the AGE/RAGE/NF-κB signaling pathway, thus improving retinopathy in diabetic mice [59]. Here, NFKB1 is linked to retinal disorder.